Navigation Links
Arena Pharmaceuticals to Report Second Quarter 2008 Financial Results and to Host Conference Call and Webcast on Tuesday, August 5, 2008
Date:7/29/2008

SAN DIEGO, July 29 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced it will report second quarter 2008 financial results after the NASDAQ Global Market closes on Tuesday, August 5, 2008. That same afternoon, Jack Lief, Arena's President and Chief Executive Officer, and Robert E. Hoffman, Arena's Vice President, Finance and Chief Financial Officer, will host a conference call at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) to discuss the second quarter 2008 financial results and to provide a corporate update.

The conference call may be accessed by dialing 877.419.6590 for domestic callers and 719.325.4872 for international callers. Please specify to the operator that you would like to join the "Arena Second Quarter Earnings Call." The conference call will be webcast live under the investor relations section of Arena's website at http://www.arenapharm.com, and will be archived there for 30 days following the call. Please connect to Arena's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Arena Pharmaceuticals

Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for the treatment of obesity. Arena's broad pipeline of novel compounds target G protein-coupled receptors, an important class of validated drug targets, and includes compounds being evaluated independentl
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Arena Pharmaceuticals to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference
2. ThreeWire Expands Presence in the Pharmaceutical Arena
3. Arena Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference
4. Arena Pharmaceuticals Announces First Quarter 2008 Financial Results
5. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results
7. Arena Pharmaceuticals to Report Fourth Quarter and Full Year 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, February 27, 2008
8. Arena Pharmaceuticals to Present at the BIO CEO & Investor Conference
9. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Second Generation Niacin Receptor Agonist Under Its Collaboration With Merck & Co., Inc.
10. Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material, Including Lorcaserin
11. Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... The chemistry, taste, and health effects of tea can vary ... the nonprofit American Botanical Council (ABC). Recent research by ... on the phytochemical compounds in tea ( Camellia sinensis ) ... in the Yunnan province of southwestern ... future of medicinal botanicals. Dr. Ahmed,s report on ...
(Date:9/15/2014)... La deuxième édition annuelle de l, ... sur la sensibilisation au plasma) sera célébrée du ... Plasma Protein Therapeutics Association (PPTA) et ... à : , Sensibiliser davantage la ... plasma-aphérèse , Reconnaître la contribution des donneurs ...
(Date:9/15/2014)... Hydro Dynamics, Inc. (HDI) of Rome, ... will be partnering with Proteaf Technologies (Proteaf) of ... implementing its Shock Wave Power Reactor (SPR) cavitation ... flow chemistry through process intensification has been widely ... for decades. The continuous chemistry has been ...
(Date:9/14/2014)... particularly ingenious when it comes to survival strategies. They ... hostile environment, for example during treatment with antibiotics. A ... a protective slime capsule consisting of sugar chains and ... have for the first time created a detailed three-dimensional ... blocks cross the bacterial cell wall, a crucial step ...
Breaking Biology Technology:Tea Taste and Quality Affected by Climate Change 2Tea Taste and Quality Affected by Climate Change 3Tea Taste and Quality Affected by Climate Change 4L' International Plasma Awareness Week célébrera les donneurs et braquera les projecteurs sur les maladies rares 2L' International Plasma Awareness Week célébrera les donneurs et braquera les projecteurs sur les maladies rares 3Hydro Dynamics Partners with the Continuous Flow Chemistry Experts of Proteaf Technologies 2New insights in survival strategies of bacteria 2
... professionals often face the challenge of delivering cost-effective ... both storage and bandwidth efficiency, while providing seamless, ... SecureZip, a new family of products designed for ... a cross-platform environment. The company also introduced a ...
... Inc. announced Wednesday that its net sales are up ... The Milwaukee-based company, which does business as Merge ... the acquisition of RIS Logic, a radiology information systems ... eFilm's picture archiving and communication system, or PACS, used ...
... has announced a new network switch and router ... second, using designs bought from a Wisconsin company. , ... Eau Claire, designs application-specific integrated circuits and systems-on-a-chip. SLE ... System Packet Interface Level 4 Phase 2, or SPI ...
Cached Biology Technology:PKWare launches new enterprise product line, adds new features to PKZip 2PKWare launches new enterprise product line, adds new features to PKZip 3Agilent's new network chip was designed in Wisconsin 2
(Date:9/15/2014)... of wild, domesticated, and domesticated-wild hybridized populations ... found that within 5 to 11 generations, ... wild populations that hybridized with domesticated populations. ... provides evidence that natural selection, over time, ... experience as a result of increased genetic ...
(Date:9/15/2014)... Vuoksi River and the subsequent rapid decrease in the ... revealed thousands of square kilometres of new, fertile land ... University of Helsinki researchers has studied the role that ... interaction between nature and humans. After dramatic shifts in ... changes and gave rise to a new, innovative culture. ...
(Date:9/15/2014)... PA, September 15, 2014 Schizophrenia is generally considered ... shares many risk factors, both genetic and environmental, with ... , The normal path for brain development is determined ... genes and a wide range of environmental factors. , ... patient populations are required in order to map the ...
Breaking Biology News(10 mins):The creation of the Vuoksi River preceded a significant cultural shift 2Brain Development in Schizophrenia Strays from the Normal Path 2
... A mutation in blood stem cells occurs in patients ... at the Moores Cancer Center at the University of ... Cell Biology and Regenerative Medicine and Comprehensive Cancer Center ... The discovery suggests that development of a very specific ...
... colleagues have produced 3-D images of ancient fossils -- 650 ... an achievement that has never been done before. , If ... Earth, Schopf said the techniques he has used, called confocal ... look at microscopic fossils inside the rocks to search for ...
... bone may rely on a few secrets from the ... Berkeley National Laboratory (Berkeley Lab) have harnessed the way ... is four times stronger than material currently used in ... variations of this substance could also be used in ...
Cached Biology News:Mutation in blood stem cells provides clues to cancer development 2Mutation in blood stem cells provides clues to cancer development 3Inside rocks, implications for finding life on Mars 2Secrets of the sea yield stronger artificial bone 2Secrets of the sea yield stronger artificial bone 3Secrets of the sea yield stronger artificial bone 4
UBN-1 (C-20)...
P2A4...
pETDuet-1 is designed for the coexpression of two target genes....
... Recognizes K+ Cl- ... shows no significant sequence ... or CCC.,SPECIES REACTIVITIES: The ... conserved in human, mouse, ...
Biology Products: